dc.contributor.author |
Bagaya, Bernard S. |
|
dc.contributor.author |
Tian, Meijuan |
|
dc.contributor.author |
Nickel, Gabrielle C. |
|
dc.contributor.author |
Vega, Jose F. |
|
dc.contributor.author |
Li, Yuejin |
|
dc.contributor.author |
He, Ping |
|
dc.contributor.author |
Klein, Katja |
|
dc.contributor.author |
Mann, Jamie F. S. |
|
dc.contributor.author |
Jiang, Wei |
|
dc.contributor.author |
Arts, Eric J. |
|
dc.contributor.author |
Gao, Yong |
|
dc.date.accessioned |
2021-01-01T21:58:13Z |
|
dc.date.available |
2021-01-01T21:58:13Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
0022-2836 |
|
dc.identifier.uri |
http://combine.alvar.ug/handle/1/48215 |
|
dc.description.abstract |
The low frequency of HIV-1 recombinants within entire viral populations in both individual patients and culture-based infection models impedes investigation of the underlying factors contributing to either the occurrence of recombinants or the survival of recombinants once they are formed. So far, most of the related studies have no consideration of recombinants' functionality. Here, we established a functional recombinant production (FRP) system to produce pure and functional HIV-1 intersubtype Env recombinants and utilized 454 pyrosequencing to investigate the distribution of over 4000 functional and non-functional recombination breakpoints from either the FRP system or dual infection cultures. The results revealed that most of the breakpoints converged in gp41 (62%) and C1 (25.3%) domains of gp120, which has strong correlation with the similarity between the two recombining sequences. Yet, the breakpoints also appeared in C2 (5.2%) and C5 (4.6%) domains not correlated with the recombining sequence similarity. Interestingly, none of the intersubtype gp120 recombinants recombined between C1 and gp41 regions either from the FRP system or from the dual infection culture, and very few from the HIV epidemic were functional. The present study suggests that the selection of functional Env recombinants is one of the reasons for the predominance of C1 and gp41 Env recombinants in the HIV epidemic, and it provides an in vitro model to mimic the selection of replication-competent HIV-1 intersubtype recombination in dual or superinfected patients. (C) 2017 Elsevier Ltd. All rights reserved. |
|
dc.description.sponsorship |
NIAID, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 AI084816] |
|
dc.description.sponsorship |
Fogarty International Center at NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R21 AI079852] |
|
dc.description.sponsorship |
CIHRCanadian Institutes of Health Research (CIHR) [HBF143165] |
|
dc.description.sponsorship |
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI049170, R01AI049170, R01AI084816, R01AI049170, R01AI049170, R01AI084816, R01AI049170, R01AI049170, R01AI084816, R01AI049170, R01AI049170, R01AI049170, R01AI049170, R01AI049170, R01AI049170, R01AI084816, R01AI049170, R21AI079852, R01AI049170, R21AI079852, R01AI049170, R01AI084816] Funding Source: NIH RePORTER |
|
dc.language |
English |
|
dc.publisher |
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD |
|
dc.relation.ispartof |
Journal of Molecular Biology |
|
dc.subject |
Human Immunodeficiency Virus Type 1 |
|
dc.subject |
Intersubtype Recombination |
|
dc.subject |
Functional Envelope Recombinant |
|
dc.title |
An in vitro Model to Mimic Selection of Replication-Competent HIV-1 Intersubtype Recombination in Dual or Superinfected Patients |
|
dc.type |
Article |
|
dc.identifier.isi |
000404702800010 |
|
dc.identifier.doi |
10.1016/j.jmb.2017.04.016 |
|
dc.identifier.pmid |
28472629 |
|
dc.publisher.city |
LONDON |
|
dc.publisher.address |
24-28 OVAL RD, LONDON NW1 7DX, ENGLAND |
|
dc.identifier.eissn |
1089-8638 |
|
dc.identifier.volume |
429 |
|
dc.identifier.issue |
14 |
|
dc.identifier.spage |
2246 |
|
dc.identifier.epage |
2264 |
|
dc.subject.wc |
Biochemistry & Molecular Biology |
|
dc.subject.sc |
Biochemistry & Molecular Biology |
|
dc.description.oa |
Green Accepted |
|
dc.description.pages |
19 |
|
dc.subject.kwp |
Immunodeficiency-Virus Type-1 |
|
dc.subject.kwp |
Avian Tumor-Viruses |
|
dc.subject.kwp |
Evolutionary History |
|
dc.subject.kwp |
Sequence Identity |
|
dc.subject.kwp |
Forms |
|
dc.subject.kwp |
Infection |
|
dc.subject.kwp |
Envelope |
|
dc.subject.kwp |
China |
|
dc.subject.kwp |
Vivo |
|
dc.subject.kwp |
Assay |
|
dc.description.affiliation |
Case Western Reserve Univ, Dept Mol Biol & Microbiol, 10900 Euclid Ave, Cleveland, OH 44106 USA |
|
dc.description.affiliation |
Case Western Reserve Univ, Dept Med, Div Infect Dis, 10900 Euclid Ave, Cleveland, OH 44106 USA |
|
dc.description.affiliation |
Makerere Univ, Sch Biomed Sci, Dept Med Microbiol, Coll Hlth Sci, Kampala N6A 3K7, Uganda |
|
dc.description.affiliation |
Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA |
|
dc.description.affiliation |
Western Univ, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada |
|
dc.description.email |
ygao387@uwo.ca |
|
dc.description.corr |
Gao, Y (corresponding author), Case Western Reserve Univ, Dept Med, Div Infect Dis, 10900 Euclid Ave, Cleveland, OH 44106 USA.; Gao, Y (corresponding author), Western Univ, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada. |
|
dc.description.orcid |
Arts, Eric/0000-0002-4880-7968 |
|
dc.description.orcid |
Ssentalo Bagaya, Bernard/0000-0002-3847-2615 |
|
dc.description.orcid |
Mann, Jamie/0000-0001-7037-1286 |
|